CAMBRIDGE, Mass., December 17, 2020 – Cadent Therapeutics, a privately held clinical stage biopharmaceutical company focused on the development of therapies for the treatment of cognitive, mood, and movement disorders, announced today that it has reached a definitive agreement with Novartis, under which Novartis will acquire all of the outstanding capital stock of Cadent Therapeutics. Upon the closing of the agreement, Cadent will receive a $210 million upfront payment and will be eligible for up to $560 million in milestone payments, for a total potential consideration of $770 million.
Cadent Therapeutics Enters Agreement to Be Acquired by Novartis
Posted on December 22, 2020
Categories: In the News
How can I volunteer for a trial/
Watch the website, http://www.clinicaltrials.gov. If you log in and key in “essential tremor” any clinical trials that are recruiting will come up (as well as clinical trials which have been completed). You can see the results of the CAD-1883 clinical trial on this site: https://clinicaltrials.gov/ct2/show/NCT03688685?term=CAD-1883&cond=Essential+Tremor&draw=2&rank=1